Celldex Therapeutics, Inc.

Diagnostics company · Hampton, New Jersey, United States · Nasdaq: CLDX

Celldex Therapeutics, Inc. is a diagnostics company headquartered in Hampton, New Jersey, United States. Its shares trade on Nasdaq under the ticker CLDX. It has received 3 US government small-business research awards (SBIR/STTR) from health agencies, $596,970 in total, most recently in 2013. It has reported private securities offerings to the US SEC, most recently $63 million sold in a notice filed in 2016.

Profile compiled from public records. Is this your company? Request a correction or update

Celldex Therapeutics at a glance

Typediagnostics company
HeadquartersHampton, New Jersey, United States
Stock listingNasdaq: CLDX
SEC industryIn Vitro & In Vivo Diagnostic Substances
SEC CIK744218

What does Celldex Therapeutics do?

US government research funding

3 SBIR/STTR small-business research awards from US health agencies, $596,970 in total (2011 to 2013). NIH funding came from the National Cancer Institute.

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $62.5 million sold (2016).

Frequently asked questions about Celldex Therapeutics

Where is Celldex Therapeutics headquartered?

Celldex Therapeutics, Inc. is headquartered in Hampton, New Jersey, United States.

What does Celldex Therapeutics do?

Celldex Therapeutics, Inc. is a diagnostics company. Its SEC industry classification is In Vitro & In Vivo Diagnostic Substances.

Is Celldex Therapeutics a public company?

Yes. Celldex Therapeutics, Inc. trades on Nasdaq under the ticker CLDX.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.